GTBPVSZSQR• 12 Months (Normalized)
GTBP vs ZSQR (GT Biopharma Inc. vs Z Squared Inc.)
Showing Closing Date Range from Oct 2, 2025 to Oct 2, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
GTBP Performance $6.1
+854.62%
GT Biopharma Inc.
Normalized Baseline0.00%
ZSQR Performance $3.97
-76.11%
Z Squared Inc.
Normalized Baseline0.00%
Alpha Spread Margin GTBP LEADS
+930.73 pts
GTBP outperforming by 930.73 percentage points
GTBPZSQR
Spread Trajectory12 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
GTBP ZSQR
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(251 dates)
| Date | GTBP Price | GTBP Gain (%) | ZSQR Price | ZSQR Gain (%) | Spread |
|---|---|---|---|---|---|
| Oct 02, 2026 | $6.10 | +854.62% | $3.97 | -76.11% | +930.73% |
| Sep 30, 2026 | $- | $4.16 | -74.97% | - | |
| Sep 29, 2026 | $6.88 | +975.90% | $4.15 | -75.03% | +1050.93% |
| Sep 28, 2026 | $6.80 | +964.16% | $4.54 | -72.68% | +1036.84% |
| Sep 25, 2026 | $6.89 | +978.25% | $3.78 | -77.26% | +1055.51% |
| Sep 24, 2026 | $6.83 | +968.86% | $3.71 | -77.68% | +1046.54% |
| Sep 23, 2026 | $7.10 | +1011.11% | $2.96 | -82.19% | +1093.30% |
| Sep 22, 2026 | $- | $2.79 | -83.21% | - | |
| Sep 21, 2026 | $7.18 | +1023.63% | $2.64 | -84.12% | +1107.75% |
| Sep 18, 2026 | $7.16 | +1020.50% | $2.68 | -83.87% | +1104.37% |
| Sep 17, 2026 | $7.49 | +1072.14% | $2.54 | -84.72% | +1156.86% |
| Sep 16, 2026 | $7.81 | +1122.22% | $2.29 | -86.22% | +1208.44% |
| Sep 15, 2026 | $9.00 | +1308.45% | $2.31 | -86.10% | +1394.55% |
| Sep 14, 2026 | $11.63 | +1720.03% | $2.76 | -83.42% | +1803.45% |
| Sep 11, 2026 | $8.61 | +1247.42% | $3.07 | -81.53% | +1328.95% |
Page 1 of 17